This may also result in an altered timeline of immune responses to SARS-CoV-2 Omicron compared to first-wave or Delta virus infection, possibly explaining why no differences in Cxcl1 or other pro-inflammatory mediators were observed. The gene discussed is CXCL1; the disease is viral infectious disease.